Prof. Vinod Menon Leads Coventry & Warwickshire Hospitals in Pioneering Weight Loss Procedure

Posted by

In a significant development for healthcare in the region, University Hospitals Coventry & Warwickshire NHS Trust has announced the introduction of a cutting-edge weight loss procedure known as Endoscopic Sleeve Gastroplasty (ESG).

Professor Vinod Menon, a distinguished laparoscopic upper gastrointestinal and obesity surgeon, shared insights into this groundbreaking procedure in an exclusive interview with BBC Coventry & Warwickshire Radio host Phil Upton.

ESG, as described by Professor Menon, involves the insertion of an endoscopic camera into the patient’s stomach, allowing surgeons to meticulously shrink it to just 30% of its original size. Unlike traditional weight loss surgeries, ESG does not involve the removal of the stomach; instead, it focuses on remodeling and reducing its volume. This innovative approach offers patients a minimally invasive option with promising outcomes.

Jules Aspinall, a beneficiary of ESG, shared her transformative experience on BBC Coventry & Warwickshire Radio, highlighting the procedure’s life-changing impact. Previously unable to walk a hundred yards, Jules now enjoys the freedom to walk for miles, enhancing her quality of life and enabling her to actively engage with her family, including her 16-month-old granddaughter.

Professor Menon emphasized the safety, efficacy, and minimally invasive nature of ESG, noting its potential to revolutionize weight loss surgery. With a projected 90-minute duration and the possibility of same-day discharge for patients, ESG offers a promising solution for individuals struggling with obesity.

The introduction of ESG at University Hospitals Coventry & Warwickshire NHS Trust aligns with national priorities to address rising obesity rates in the UK. With over 25.9% of adults in England living with obesity, the demand for effective weight loss interventions is substantial. ESG’s less invasive approach and broader eligibility criteria, catering to individuals with a BMI over 30, signify a significant advancement in tackling obesity-related health challenges.

Professor Menon underscored the importance of medical technology advancements and governmental support in advancing healthcare strategies. He highlighted ESG as a viable option for patients who may not be suitable candidates for conventional weight loss surgeries, emphasizing its role in reducing obesity levels and improving patient outcomes.

The introduction of ESG at University Hospitals Coventry & Warwickshire NHS Trust marks a milestone in the fight against obesity, offering hope and practical solutions to individuals seeking effective weight management strategies.

For further information on ESG and its availability at University Hospitals Coventry & Warwickshire NHS Trust, interested individuals are encouraged to consult with their healthcare providers.